JPML Won't Merge 12 Actions Over Plavix Injuries
The JPML agreed with Bristol-Myers and Sanofi-Aventis that the 12 lawsuits did involve some common factual issues involving the development, manufacture, regulatory approval, labeling and marketing of Plavix.
But the panel said the 10 actions pending in New Jersey federal court, filed in 2006 and 2007, were far more advanced than the remaining...
Already a subscriber? Click here to login